Am J Dermatopathol

1. ZOU Y, Li L, Xia R, Wang F, et al
   Accuracy of Confocal Microscopy for the Diagnosis of Acral Lentiginous Melanoma and Acral Melanocytic Nevi.
   Am J Dermatopathol. 2025 Aug 6. doi: 10.1097/DAD.0000000000003099.
   

   >> Share

   
   

   
   Anticancer Res

2. AZUMI J, Takeda T, Shimada Y, Aso H, et al
   Combination of 3-(Trihydroxygermyl)propanoic Acid (THGP) and Lipopolysaccharide Promotes Macrophage Differentiation to M1, and Antitumor Activity.
   Anticancer Res. 2025;45:3425-3440.
   

   >> Share

   
   
3. YAMADA T, Iwasawa T, Shimizu Y, Kato K, et al
   Resveratrol Enhances Sulfasalazine-induced Ferroptosis by Promoting Iron Ion Accumulation and Lipid Peroxidation in Cancer Cells.
   Anticancer Res. 2025;45:3231-3244.
   

   >> Share

   
   

   
   Cancer

4. MILHEM MM, Zakharia Y, Davar D, Buchbinder EI, et al
   Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b study.
   Cancer. 2025;131:e70022.
   

   >> Share

   
   

   
   J Am Acad Dermatol

5. LIU Q, Yang H, Yu Y, Zhong S, et al
   Cutaneous Melanoma.
   J Am Acad Dermatol. 2025 Jul 31:S0190-9622(25)02548.
   

   >> Share

   
   

   
   J Immunother

6. BHATNAGAR S, Revuri V, Merali C, Wang B, et al
   A Novel Imidazoquinoline With TLR 7/8, STING, and Inflammasome Activity Demonstrates Antitumor Efficacy in Mouse Melanoma and Neu-Driven Mammary Adenocarcinoma.
   J Immunother. 2025 Aug 6. doi: 10.1097/CJI.0000000000000571.
   

   >> Share

   
   

   
   J Invest Dermatol

7. CHHABRA G, Su S, Shirley CA, Thornton J, et al
   A melanoma-specific gene network analysis identifies MZB1 (marginal zone B and B1 cell-specific protein) as a potential tumor promoter.
   J Invest Dermatol. 2025 Jul 30:S0022-202X(25)02310.
   

   >> Share

   
   
8. VAN DEN HURK K, Lommen K, Coussement L, van den Kerkhof D, et al
   Comprehensive analysis of the melanoma DNA methylome identifies Lymphocyte Antigen 75 (LY75) methylation as an independent marker predicting poor clinical outcome.
   J Invest Dermatol. 2025 Jul 30:S0022-202X(25)02311.
   

   >> Share

   
   

   
   Melanoma Res

9. CHANG RC, Brunsgaard EK, Reid DC
   Treatment and survival disparities in acral lentiginous melanoma: a National Cancer Database multivariate analysis.
   Melanoma Res. 2025 Aug 5. doi: 10.1097/CMR.0000000000001059.
   

   >> Share

   
   

   
   Nat Med

10. BORGERS JSW, Lenkala D, Kohler V, Jackson EK, et al
    Publisher Correction: Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial.
    Nat Med. 2025 Aug 4. doi: 10.1038/s41591-025-03896.
    

    >> Share

    
    
11. MIGLINO N, Toussaint NC, Ring A, Bonilla X, et al
    Publisher Correction: Feasibility of multiomics tumor profiling for guiding treatment of melanoma.
    Nat Med. 2025 Aug 1. doi: 10.1038/s41591-025-03904.
    

    >> Share

    
    

    
    Oncogene

12. HUANG S, Deng W, Wang P, Yan Y, et al
    Retraction Note: Fermitin family member 2 promotes melanoma progression by enhancing the binding of p-alpha-Pix to Rac1 to activate the MAPK pathway.
    Oncogene. 2025 Aug 5. doi: 10.1038/s41388-025-03524.
    

    >> Share

    
    

    
    Ophthalmology

13. NISSEN K, Ravn Jorgensen AH, Rosthoj S, Thomsen S, et al
    Survival Outcomes of Uveal Melanoma Involving the Anterior Chamber of the Eye. A National Retrospective Cohort Study: Denmark, 1943-2022.
    Ophthalmology. 2025 Jul 30:S0161-6420(25)00461.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share